C. Lu and A. Shervington, Chemoresistance in gliomas, Molecular and Cellular Biochemistry, vol.71, issue.6, pp.71-80, 2008.
DOI : 10.1007/s11010-008-9722-8

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4

D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002.
DOI : 10.3322/canjclin.49.1.33

G. Keles, K. Lamborn, and M. Berger, Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome, Journal of Neurosurgery, vol.95, issue.5, pp.735-745, 2001.
DOI : 10.3171/jns.2001.95.5.0735

M. Khasraw and A. Lassman, Advances in the Treatment of Malignant Gliomas, Current Oncology Reports, vol.27, issue.1, pp.26-33, 2010.
DOI : 10.1007/s11912-009-0077-4

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

R. Stupp, M. Hegi, W. Mason, M. Van-den-bent, M. Taphoorn et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009.
DOI : 10.1016/S1470-2045(09)70025-7

A. Hottinger and R. Stupp, Strat??gies th??rapeutiques pour le traitement des gliomes, Revue Neurologique, vol.164, issue.6-7, pp.523-530, 2008.
DOI : 10.1016/j.neurol.2008.03.012

C. Nieder, M. Mehta, and R. Jalali, Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients, Clinical Oncology, vol.21, issue.7, pp.515-524, 2009.
DOI : 10.1016/j.clon.2009.05.003

Z. Miklan, R. Szabo, V. Zsoldos-mady, J. Remenyi, Z. Banoczi et al., New ferrocene containing peptide conjugates: Synthesis and effect on human leukemia (HL-60) cells, Biopolymers, vol.77, issue.2, pp.108-114, 2007.
DOI : 10.1002/bip.20696

C. Zhang and S. Lippard, New metal complexes as potential therapeutics, Current Opinion in Chemical Biology, vol.7, issue.4, pp.481-489, 2003.
DOI : 10.1016/S1367-5931(03)00081-4

E. Hillard, A. Vessieres, L. Bideau, F. Plazuk, D. Spera et al., A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents, ChemMedChem, vol.11, issue.5, pp.551-559, 2006.
DOI : 10.1002/cmdc.200500035

P. Bruijnincx and P. Sadler, New trends for metal complexes with anticancer activity, Current Opinion in Chemical Biology, vol.12, issue.2
DOI : 10.1016/j.cbpa.2007.11.013

A. Vessieres, S. Top, P. Pigeon, E. Hillard, L. Boubeker et al., Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005.
DOI : 10.1021/jm050251o

URL : https://hal.archives-ouvertes.fr/hal-01230403

E. Hillard, A. Vessières, L. Thouin, G. Jaouen, and C. Amatore, Ferrocene-mediated protoncoupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027

URL : https://hal.archives-ouvertes.fr/inserm-00343557

A. Nguyen, V. Marsaud, C. Bouclier, S. Top, A. Vessieres et al., Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment, International Journal of Pharmaceutics, vol.347, issue.1-2, pp.128-135, 2008.
DOI : 10.1016/j.ijpharm.2007.06.033

URL : https://hal.archives-ouvertes.fr/hal-00180710

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010.
DOI : 10.1007/s11095-009-0006-0

Y. Mardor, O. Rahav, Y. Zauberman, Z. Lidar, A. Ocherashvilli et al., Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image Monitoring, Cancer Research, vol.65, issue.15, pp.6858-6863, 2005.
DOI : 10.1158/0008-5472.CAN-05-0161

M. I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli et al., Strategy for effective brain drug delivery, European Journal of Pharmaceutical Sciences, vol.40, issue.5, pp.385-403, 2010.
DOI : 10.1016/j.ejps.2010.05.003

J. P. Benoit, 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas, Eur J Nucl Med Mol Imaging, vol.35, pp.1838-1846, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00343438

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010.
DOI : 10.1007/s11095-009-0006-0

E. Allard, C. Passirani, and J. P. Benoit, Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, issue.12, pp.2302-2318, 2009.
DOI : 10.1016/j.biomaterials.2009.01.003

N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

N. T. Huynh, E. Roger, N. Lautram, J. P. Benoit, and C. Passirani, The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010.
DOI : 10.2217/nnm.10.113

G. Jaouen, S. Top, A. Vessières, A. , and R. , New paradigms for synthetic pathways inspired by bioorganometallic chemistry, Journal of Organometallic Chemistry, vol.600, issue.1-2, pp.23-36, 2000.
DOI : 10.1016/S0022-328X(00)00036-X

G. Jaouen, S. Top, A. Vessières, G. Leclercq, J. Quivy et al., The first organometallic antioestrogens and their antiproliferative effects, Comptes Rendus de l'Academie des Sciences -Series IIc: Chemistry, pp.89-93, 2000.
DOI : 10.1016/S1387-1609(00)00118-3

S. Joshi, P. M. Meyers, and E. Ornstein, Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008.
DOI : 10.1097/ALN.0b013e318182c81b

L. Lemaire, F. Franconi, J. J. Lejeune, P. Jallet, R. et al., Improving the detection of low concentration metabolites in magnetic resonance spectroscopy by digital filtering, Medical & Biological Engineering & Computing, vol.39, issue.1, pp.244-246, 1999.
DOI : 10.1007/BF02513293

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4

E. H. Luh, S. R. Shackford, M. A. Shatos, and J. A. Pietropaoli, The Effects of Hyperosmolarity on the Viability and Function of Endothelial Cells, Journal of Surgical Research, vol.60, issue.1, pp.122-128, 1996.
DOI : 10.1006/jsre.1996.0020

M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin et al., Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010.
DOI : 10.1016/j.biomaterials.2009.09.044

URL : https://hal.archives-ouvertes.fr/inserm-00491402

H. B. Newton, Intra-Arterial Chemotherapy, Handbook of Brain Tumor Chemotherapy, pp.247-261, 2006.
DOI : 10.1016/B978-012088410-0/50055-X

W. Slone, C. , and D. W. , Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors, J Neurooncol, vol.61, pp.35-44, 2003.

W. M. Pardridge, The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1, 2005.
DOI : 10.1602/neurorx.2.1.3

D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002.
DOI : 10.3322/canjclin.49.1.33

L. Petit, F. Masson, V. Cottenceau, and F. Sztark, Hypernatrémie contrôlée. Annales Françaises d'Anesthésie et de Réanimation, pp.828-837, 2006.

S. I. Rapoport, Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.217-230, 2000.
DOI : 10.1023/A:1007049806660

B. C. Schem and B. K. Krossnes, Enhancement of ACNU treatment of the BT4an rat glioma by local brain hyperthermia and intra-arterial drug administration, European Journal of Cancer, vol.31, issue.11, pp.1869-1874, 1995.
DOI : 10.1016/0959-8049(95)00381-R

R. 1. Jaouen, G. Top, S. Vessières, A. , and A. R. , New paradigms for synthetic pathways inspired by bioorganometallic chemistry, Journal of Organometallic Chemistry, vol.600, issue.1-2, pp.23-36, 2000.
DOI : 10.1016/S0022-328X(00)00036-X

A. Vessieres, S. Top, P. Pigeon, E. Hillard, L. Boubeker et al., Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005.
DOI : 10.1021/jm050251o

URL : https://hal.archives-ouvertes.fr/hal-01230403

S. Top, A. Vessieres, G. Leclercq, J. Quivy, J. Tang et al., Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines, Chemistry - A European Journal, vol.9, issue.21, pp.5223-5236, 2003.
DOI : 10.1002/chem.200305024

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027

URL : https://hal.archives-ouvertes.fr/inserm-00343557

A. Nguyen, V. Marsaud, C. Bouclier, S. Top, A. Vessieres et al., Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment, International Journal of Pharmaceutics, vol.347, issue.1-2
DOI : 10.1016/j.ijpharm.2007.06.033

URL : https://hal.archives-ouvertes.fr/hal-00180710

B. Heurtault, P. Saulnier, B. Pech, J. Proust, and J. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002.
DOI : 10.1023/A:1016121319668

N. Huynh, C. Passirani, P. Saulnier, and J. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

E. Allard, N. Huynh, A. Vessieres, P. Pigeon, G. Jaouen et al., Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009.
DOI : 10.1016/j.ijpharm.2009.05.031

URL : https://hal.archives-ouvertes.fr/hal-01230396

A. Vonarbourg, C. Passirani, P. Saulnier, and J. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006.
DOI : 10.1016/j.biomaterials.2006.03.039

N. Huynh, E. Roger, N. Lautram, J. Benoit, and C. Passirani, The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010.
DOI : 10.2217/nnm.10.113

S. Ballot, N. Noiret, F. Hindre, B. Denizot, E. Garin et al., 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, European Journal of Nuclear Medicine and Molecular Imaging, vol.242, issue.5, pp.602-607, 2006.
DOI : 10.1007/s00259-005-0007-0

URL : http://doi.org/10.1007/s00259-005-0007-0

H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, Journal of Controlled Release, vol.65, issue.1-2, pp.271-284, 2000.
DOI : 10.1016/S0168-3659(99)00248-5

M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin et al., Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010.
DOI : 10.1016/j.biomaterials.2009.09.044

URL : https://hal.archives-ouvertes.fr/inserm-00491402

M. Papadopoulos, S. Saadoun, D. Binder, G. Manley, S. Krishna et al., Molecular mechanisms of brain tumor edema, Neuroscience, vol.129, issue.4, pp.1011-1020, 2004.
DOI : 10.1016/j.neuroscience.2004.05.044

G. Jaouen, S. Top, A. Vessières, G. Leclercq, J. Quivy et al., The first organometallic antioestrogens and their antiproliferative effects. Comptes Rendus de l'Academie des Sciences -Series IIc, Chemistry, vol.3, issue.2, pp.89-93, 2000.

E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-pouessel et al., A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1722, 2006.
DOI : 10.1158/1535-7163.MCT-06-0289

URL : https://hal.archives-ouvertes.fr/hal-00358958

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006.
DOI : 10.1002/jbm.a.30711

C. Passirani, G. Barratt, J. Devissaguet, and D. Labarre, Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sciences, vol.62, issue.8, pp.775-785, 1998.
DOI : 10.1016/S0024-3205(97)01175-2

S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae et al., Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester, Cancer Res, vol.42, issue.4, pp.1530-1536, 1982.

A. Vonarbourg, P. Saulnier, C. Passirani, and J. Benoit, Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface, ELECTROPHORESIS, vol.15, issue.11, pp.2066-2075, 2005.
DOI : 10.1002/elps.200410145

A. Beduneau, P. Saulnier, A. N. Hindre, F. Passirani, C. Rajerison et al., Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties, Pharmaceutical Research, vol.134, issue.109, pp.2190-2199, 2006.
DOI : 10.1007/s11095-006-9061-y

J. Park, P. Fong, J. Lu, K. Russell, C. Booth et al., PEGylated PLGA nanoparticles for the improved delivery of doxorubicin, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.4, pp.410-418, 2009.
DOI : 10.1016/j.nano.2009.02.002

T. Yang, F. Cui, M. Choi, J. Cho, S. Chung et al., Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation, International Journal of Pharmaceutics, vol.338, issue.1-2, pp.317-326, 2007.
DOI : 10.1016/j.ijpharm.2007.02.011

G. Mattheolabakis, E. Taoufik, S. Haralambous, M. Roberts, and K. Avgoustakis, In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.71, issue.2, pp.190-195, 2009.
DOI : 10.1016/j.ejpb.2008.09.011

W. Zamboni, S. Ramalingam, D. Friedland, R. Edwards, R. Stoller et al., Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies, Clinical Cancer Research, vol.15, issue.4, pp.1466-1472, 2009.
DOI : 10.1158/1078-0432.CCR-08-1405

C. Passirani and J. Benoit, Complement Activation by Injectable Colloidal Drug Carriers
DOI : 10.1201/9780203492321.ch6

R. Suzuki, T. Takizawa, Y. Kuwata, M. Mutoh, N. Ishiguro et al., Effective anti-tumor activity of oxaliplatin encapsulated in transferrin???PEG-liposome, International Journal of Pharmaceutics, vol.346, issue.1-2, pp.143-150, 2008.
DOI : 10.1016/j.ijpharm.2007.06.010

S. Murphy, R. Davey, X. Gu, M. Haywood, L. Mccann et al., Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model, Journal of Neuro-Oncology, vol.59, issue.2, pp.181-189, 2007.
DOI : 10.1007/s11060-007-9406-3

W. Pardridge, The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1
DOI : 10.1602/neurorx.2.1.3

M. Segal, The choroid plexuses and the barriers between the blood and the cerebrospinal fluid, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.183-196, 2000.
DOI : 10.1023/A:1007045605751

U. Sharma, A. Sharma, R. Chau, and R. Straubinger, Liposome-mediated therapy of intracranial brain tumors in a rat model, Pharmaceutical Research, vol.14, issue.8, pp.992-998, 1997.
DOI : 10.1023/A:1012136925030

J. Gleadle and P. Ratcliffe, Hypoxia and the regulation of gene expression, Molecular Medicine Today, vol.4, issue.3, pp.122-129, 1998.
DOI : 10.1016/S1357-4310(97)01198-2

B. Blouw, H. Song, T. Tihan, J. Bosze, N. Ferrara et al., The hypoxic response of tumors is dependent on their microenvironment, Cancer Cell, vol.4, issue.2, pp.133-146, 2003.
DOI : 10.1016/S1535-6108(03)00194-6

M. Machein and K. Plate, VEGF in brain tumors, Journal of Neuro-Oncology, vol.50, issue.1/2, pp.109-120, 2000.
DOI : 10.1023/A:1006416003964

N. Huynh, E. Roger, N. Lautram, J. Benoit, and C. Passirani, The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010.
DOI : 10.2217/nnm.10.113

B. Heurtault, P. Saulnier, B. Pech, J. Proust, and J. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002.
DOI : 10.1023/A:1016121319668

N. Huynh, C. Passirani, P. Saulnier, and J. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

A. Beduneau, F. Hindre, A. Clavreul, J. Leroux, P. Saulnier et al., Brain targeting using novel lipid nanovectors, Journal of Controlled Release, vol.126, issue.1, pp.44-49, 2008.
DOI : 10.1016/j.jconrel.2007.11.001

URL : https://hal.archives-ouvertes.fr/inserm-00258097

M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin et al., Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010.
DOI : 10.1016/j.biomaterials.2009.09.044

URL : https://hal.archives-ouvertes.fr/inserm-00491402

E. Hillard, A. Vessieres, L. Bideau, F. Plazuk, D. Spera et al., A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents, ChemMedChem, vol.11, issue.5, pp.551-559, 2006.
DOI : 10.1002/cmdc.200500035

A. Vessieres, S. Top, P. Pigeon, E. Hillard, L. Boubeker et al., Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005.
DOI : 10.1021/jm050251o

URL : https://hal.archives-ouvertes.fr/hal-01230403

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027

URL : https://hal.archives-ouvertes.fr/inserm-00343557

E. Allard, N. Huynh, A. Vessieres, P. Pigeon, G. Jaouen et al., Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009.
DOI : 10.1016/j.ijpharm.2009.05.031

URL : https://hal.archives-ouvertes.fr/hal-01230396

A. Bocquet, R. Berges, R. Frank, P. Robert, A. Peterson et al., Neurofilaments Bind Tubulin and Modulate Its Polymerization, Journal of Neuroscience, vol.29, issue.35, pp.11043-11054, 2009.
DOI : 10.1523/JNEUROSCI.1924-09.2009

J. Vakkila and M. Lotze, Opinion: Inflammation and necrosis promote tumour growth, Nature Reviews Immunology, vol.94, issue.8, pp.641-648, 2004.
DOI : 10.1038/21460

L. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1006/cyto.1996.0074

S. Grivennikov, F. Greten, and K. M. , Immunity, inflammation, and cancer. Cell 1. Khasraw M, Lassman AB: Advances in the treatment of malignant gliomas, Curr Oncol Rep, vol.12, issue.1, pp.26-33, 2010.

S. Vinchon-petit, D. Jarnet, A. Paillard, J. Benoit, E. Garcion et al., In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy, Journal of Neuro-Oncology, vol.28, issue.2, pp.195-205, 2010.
DOI : 10.1007/s11060-009-0012-4

A. Beduneau, P. Saulnier, F. Hindre, A. Clavreul, J. Leroux et al., Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab??? fragments, Biomaterials, vol.28, issue.33, pp.4978-4990, 2007.
DOI : 10.1016/j.biomaterials.2007.05.014

URL : https://hal.archives-ouvertes.fr/inserm-00198713

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010.
DOI : 10.1007/s11095-009-0006-0

H. Schmidek, S. Nielsen, A. Schiller, and J. Messer, Morphological studies of rat brain tumors induced by N-nitrosomethylurea, Journal of Neurosurgery, vol.34, issue.3, pp.335-340, 1971.
DOI : 10.3171/jns.1971.34.3.0335

P. Benda, K. Someda, J. Messer, and W. Sweet, Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture, Journal of Neurosurgery, vol.34, issue.3, pp.310-323, 1971.
DOI : 10.3171/jns.1971.34.3.0310

M. Castro, R. Cowen, I. Williamson, A. David, M. Jimenez-dalmaroni et al., Current and future strategies for the treatment of malignant brain tumors, Pharmacology & Therapeutics, vol.98, issue.1, pp.71-108, 2003.
DOI : 10.1016/S0163-7258(03)00014-7

E. Allard, Apports des nanocapsules lipidiques dans le traitement local des gliomes malins: apllication à l'encapsulation de complexes lipophiles métalliques, Thèse de doctorat, 2008.

J. Adam, M. Biston, A. Joubert, A. Charvet, L. Bas et al., Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood???brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.4, pp.1173-1182, 2005.
DOI : 10.1016/j.ijrobp.2004.12.026

URL : https://hal.archives-ouvertes.fr/inserm-00388910

W. Yang, R. Barth, J. Rotaru, M. Moeschberger, D. Joel et al., Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine, Journal of Neuro-Oncology, vol.33, issue.1/2, pp.59-70, 1997.
DOI : 10.1023/A:1005769214899

P. Kozler and J. Pokorny, Altered blood-brain barrier permeability and its effect on the distribution of Evans blue and sodium fluorescein in the rat brain applied by intracarotid injection, Physiol Res, vol.52, issue.5, pp.607-614, 2003.

D. Groothuis, The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery, Neuro-Oncology, vol.2, issue.1, pp.45-59, 2000.
DOI : 10.1215/15228517-2-1-45

S. Joshi, P. Meyers, and E. Ornstein, Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008.
DOI : 10.1097/ALN.0b013e318182c81b

S. Rapoport, Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.217-230, 2000.
DOI : 10.1023/A:1007049806660

C. Vanpouille, F. Lacoeuille, E. Garcion, L. Lemaire, F. Bouchet et al., Fractionated internal radiation with stereotaxic injection of 188Re-loaded lipid nanocapsules in a rat glioblastoma model, J Nucl Med, vol.50, p.578, 2009.

A. Vonarbourg, A. Sapin, L. Lemaire, F. Franconi, P. Menei et al., Characterization and detection of experimental rat gliomas using magnetic resonance imaging, Magnetic Resonance Materials in Physics, Biology and Medicine, vol.4, issue.3-6, pp.3-6, 2004.
DOI : 10.1007/s10334-004-0049-5

E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-pouessel et al., A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1722, 2006.
DOI : 10.1158/1535-7163.MCT-06-0289

URL : https://hal.archives-ouvertes.fr/hal-00358958

J. Vakkila and M. Lotze, Opinion: Inflammation and necrosis promote tumour growth, Nature Reviews Immunology, vol.94, issue.8, pp.641-648, 2004.
DOI : 10.1038/21460

L. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1006/cyto.1996.0074

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006.
DOI : 10.1002/jbm.a.30711

S. Ballot, N. Noiret, F. Hindre, B. Denizot, E. Garin et al., 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, European Journal of Nuclear Medicine and Molecular Imaging, vol.242, issue.5, pp.602-607, 2006.
DOI : 10.1007/s00259-005-0007-0

M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin et al., Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010.
DOI : 10.1016/j.biomaterials.2009.09.044

URL : https://hal.archives-ouvertes.fr/inserm-00491402

A. Vonarbourg, C. Passirani, P. Saulnier, and J. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006.
DOI : 10.1016/j.biomaterials.2006.03.039

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027

URL : https://hal.archives-ouvertes.fr/inserm-00343557

J. Crown, O. Leary, and M. , The taxanes: an update, The Lancet, vol.355, issue.9210, pp.1176-1178, 2000.
DOI : 10.1016/S0140-6736(00)02074-2

E. Roger, F. Lagarce, and J. Benoit, The gastrointestinal stability of lipid nanocapsules, International Journal of Pharmaceutics, vol.379, issue.2, pp.260-265, 2009.
DOI : 10.1016/j.ijpharm.2009.05.069

J. Hureaux, F. Lagarce, F. Gagnadoux, A. Clavreul, J. Benoit et al., The adaptation of lipid nanocapsule formulations for blood administration in animals, International Journal of Pharmaceutics, vol.379, issue.2, pp.266-269, 2009.
DOI : 10.1016/j.ijpharm.2009.05.033

D. Emerson, R. Bendele, E. Brown, S. Chiang, J. Desjardins et al., Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan, Clin Cancer Res, vol.6, issue.7, pp.2903-2912, 2000.

R. Suzuki, T. Takizawa, Y. Kuwata, M. Mutoh, N. Ishiguro et al., Effective anti-tumor activity of oxaliplatin encapsulated in transferrin???PEG-liposome, International Journal of Pharmaceutics, vol.346, issue.1-2, pp.143-150, 2008.
DOI : 10.1016/j.ijpharm.2007.06.010

S. Murphy, R. Davey, X. Gu, M. Haywood, L. Mccann et al., Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model, Journal of Neuro-Oncology, vol.59, issue.2, pp.181-189, 2007.
DOI : 10.1007/s11060-007-9406-3

J. Kreuter, Nanoparticulate systems for brain delivery of drugs, Advanced Drug Delivery Reviews, vol.47, issue.1, pp.65-81, 2001.
DOI : 10.1016/S0169-409X(00)00122-8

J. Kreuter, Application of nanoparticles for the delivery of drugs to the brain, International Congress Series, vol.1277, pp.85-94, 2005.
DOI : 10.1016/j.ics.2005.02.014

S. Gelperina, A. Khalansky, I. Skidan, Z. Smirnova, A. Bobruskin et al., Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma, Toxicology Letters, vol.126, issue.2, pp.131-141, 2002.
DOI : 10.1016/S0378-4274(01)00456-8

S. Steiniger, J. Kreuter, A. Khalansky, I. Skidan, A. Bobruskin et al., Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles, International Journal of Cancer, vol.74, issue.5, pp.759-767, 2004.
DOI : 10.1002/ijc.20048

P. Calvo, B. Gouritin, H. Chacun, D. Desmaele, D. Angelo et al., Longcirculating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery, Pharmaceutical Research, vol.18, issue.8, pp.1157-1166, 2001.
DOI : 10.1023/A:1010931127745

J. Olivier, L. Fenart, R. Chauvet, C. Pariat, R. Cecchelli et al., Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity, Pharmaceutical Research, vol.16, issue.12, pp.1836-1842, 1999.
DOI : 10.1023/A:1018947208597

URL : https://hal.archives-ouvertes.fr/hal-00534822

M. Peracchia, R. Gref, Y. Minamitake, A. Domb, N. Lotan et al., PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1, Journal of Controlled Release, vol.46, issue.3, pp.223-231, 1997.
DOI : 10.1016/S0168-3659(96)01597-0

R. Hong, C. Huang, Y. Tseng, V. Pang, S. Chen et al., Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?, Clin Cancer Res, vol.5, issue.11, pp.3645-3652, 1999.

R. Duncan, Polymer conjugates as anticancer nanomedicines, Nature Reviews Cancer, vol.54, issue.9, pp.688-701, 2006.
DOI : 10.1038/nrc1958

S. Essa, J. Rabanel, and P. Hildgen, Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d, l-lactide) (PLA) based nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.96-106, 2010.
DOI : 10.1016/j.ejpb.2010.03.002

W. Pardridge, Drug and gene targeting to the brain via blood???brain barrier receptor-mediated transport systems, International Congress Series, vol.1277, pp.49-62, 2005.
DOI : 10.1016/j.ics.2005.02.011

A. Beduneau, F. Hindre, A. Clavreul, J. Leroux, P. Saulnier et al., Brain targeting using novel lipid nanovectors, Journal of Controlled Release, vol.126, issue.1, pp.44-49, 2008.
DOI : 10.1016/j.jconrel.2007.11.001

URL : https://hal.archives-ouvertes.fr/inserm-00258097

W. Hall, Transferrin receptor on glioblastoma multiforme, J Neurosurg, vol.74, issue.2, p.313

S. Gosk, C. Vermehren, G. Storm, and T. Moos, Targeting Anti???Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion, Journal of Cerebral Blood Flow & Metabolism, vol.14, issue.11, pp.1193-1204, 2004.
DOI : 10.1097/01.WCB.0000135592.28823.47

A. Bocquet, R. Berges, R. Frank, P. Robert, A. Peterson et al., Neurofilaments Bind Tubulin and Modulate Its Polymerization, Journal of Neuroscience, vol.29, issue.35, pp.11043-11054, 2009.
DOI : 10.1523/JNEUROSCI.1924-09.2009

R. Berges, A. Peterson, and J. Eyer, A peptide corresponding to a neurofilament tubulinbinding site targets glioma cells and inhibits their proliferation

R. 1. Sparreboom, A. Karlsson, and M. , Introduction, Investigational New Drugs, vol.21, issue.2, pp.139-140, 2003.
DOI : 10.1163/9789004285620_002

D. Stewart, The role of chemotherapy in the treatment of gliomas in adults, Cancer Treatment Reviews, vol.16, issue.3, pp.129-160, 1989.
DOI : 10.1016/0305-7372(89)90007-8

D. Miller, J. Bay, R. Lederman, J. Purvis, L. Rogers et al., Ocular and Orbital Toxicity Following Intracarotid Injection of BCNU (Carmustine) and Cisplatinum for Malignant Gliomas, Ophthalmology, vol.92, issue.3, pp.402-406, 1985.
DOI : 10.1016/S0161-6420(85)34036-8

C. Margo and F. Murtagh, Ocular and Orbital Toxicity After Intracarotid Cisplatin Therapy, American Journal of Ophthalmology, vol.116, issue.4, pp.508-509, 1993.
DOI : 10.1016/S0002-9394(14)71417-5

A. Lauer, J. Wobig, W. Shults, E. Neuwelt, and M. Wilson, Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy, American Journal of Ophthalmology, vol.127, issue.2, pp.230-233, 1999.
DOI : 10.1016/S0002-9394(98)00346-8

H. Wu, A. Lee, D. Lehane, T. Chi, and R. Lewis, Ocular and Orbital Complications of Intraarterial Cisplatin A Case Report, Journal of Neuro-Ophthalmology, vol.17, issue.3, pp.195-198, 1997.
DOI : 10.1097/00041327-199709000-00010

A. Stevens and D. Spooner, Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer, Clin Oncol (R Coll Radiol), vol.13, issue.6, pp.438-440, 2001.

S. Joshi, P. Meyers, and E. Ornstein, Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008.
DOI : 10.1097/ALN.0b013e318182c81b

P. Kozler and J. Pokorny, Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis, Sb Lek, vol.104, issue.3, pp.255-262, 2003.

C. Heldin, K. Rubin, K. Pietras, and A. Östman, High interstitial fluid pressure ??? an obstacle in cancer therapy, Nature Reviews Cancer, vol.74, issue.10, pp.806-813, 2004.
DOI : 10.1038/74725

D. Fukumura and R. Jain, Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization, Microvascular Research, vol.74, issue.2-3, pp.72-84, 2007.
DOI : 10.1016/j.mvr.2007.05.003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100036

E. Hillard, A. Vessières, L. Thouin, G. Jaouen, and C. Amatore, Ferrocene-mediated protoncoupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates

G. Sihn, T. Walter, J. Klein, I. Queguiner, H. Iwao et al., and growth reduction of implanted glioma, FEBS Letters, vol.259, issue.5, pp.962-966, 2007.
DOI : 10.1016/j.febslet.2007.01.079

URL : https://hal.archives-ouvertes.fr/hal-00166409

M. Castro, R. Cowen, I. Williamson, A. David, M. Jimenez-dalmaroni et al., Current and future strategies for the treatment of malignant brain tumors, Pharmacology & Therapeutics, vol.98, issue.1, pp.71-108, 2003.
DOI : 10.1016/S0163-7258(03)00014-7

N. Kee, S. Sivalingam, R. Boonstra, and J. Wojtowicz, The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis, Journal of Neuroscience Methods, vol.115, issue.1, pp.97-105, 2002.
DOI : 10.1016/S0165-0270(02)00007-9

A. Hara, M. Niwa, T. Iwai, M. Nakashima, Y. Bunai et al., Neuronal apoptosis studied by a sequential TUNEL technique: a method for tract-tracing, Brain Research Protocols, vol.4, issue.2, pp.140-146, 1999.
DOI : 10.1016/S1385-299X(99)00012-4

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

N. Huynh, N. N. Trinh, . Quynh, T. Tran, and . Van-anh, Vo Phung Nguyen The Fifth Indochina Conference on Pharmaceutical Sciences, 2007.

P. Nguyen-thi, . Khue, . Nguyen-nhu, . Ho, . Vo-phung-nguyen et al., Nguyen Hoang Anh The Fifth Indochina Conference on Pharmaceutical Sciences, 2007.

C. Fossey, N. Huynh, A. Vu, A. Vidu, I. Zarafu et al., Synthesis and anti-HIV evaluation of hybrid-type prodrugs conjugating HIV integrase inhibitors with d4t by self-cleavable spacers containing an amino acid residue, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.56, issue.4, pp.608-619, 2007.
DOI : 10.1021/jm00020a007

N. Huynh, N. Nguyen, T. Tran, and P. Vo, Hypolipidemic effect of extracts from Abelmoschus esculentus L. ? Malvaceae on tyloxapol -induced hyperlipidemia in mice

E. Allard, N. Huynh, A. Vessieres, P. Pigeon, G. Jaouen et al., Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009.
DOI : 10.1016/j.ijpharm.2009.05.031

URL : https://hal.archives-ouvertes.fr/hal-01230396

N. Huynh, C. Passirani, P. Saulnier, and J. Benoit, Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009.
DOI : 10.1016/j.ijpharm.2009.04.026

N. Huynh, E. Roger, N. Lautram, J. Benoit, and C. Passirani, The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010.
DOI : 10.2217/nnm.10.113

N. Huynh, C. Passirani, E. Allard-vannier, L. Lemaire, J. Roux et al., Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma, International Journal of Pharmaceutics, vol.423, issue.1, 2011.
DOI : 10.1016/j.ijpharm.2011.04.037

N. Huynh, M. Morille, J. Bejaud, P. Legras, A. Vessieres et al., Treatment of 9L gliosarcoma in rats by ferrociphenol loaded lipid nanocapsules based on passive targeting strategy through EPR effect. Submitted for publication in Pharmaceutical Research An active targeting strategy through ferrociphenol-loaded lipid nanocapsules for the treatment of 9L rat gliosarcoma

M. Roger, A. Clavreul, N. Huynh, C. Passirani, P. Schiller et al., Ferrociphenol loaded lipid nanocapsules deliver by mesenchymal stem cells in brain tumor therapy, International Journal of Pharmaceutics